By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Puma Biotechnology 

10940 Wilshire Blvd, Suite 600

Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


Company News
Puma Biotechnology (PBYI) Announces Underwriters’ Full Exercise Of Option To Purchase Additional Shares 1/23/2015 10:25:21 AM
Puma Biotechnology (PBYI) Announces Proposed Public Offering 1/21/2015 12:51:29 PM
Puma Biotechnology (PBYI) To Present At J.P. Morgan Healthcare Conference 1/6/2015 11:27:00 AM
Puma Biotechnology (PBYI) Announces Positive Interim PB272 (Neratinib) Phase 2 Data At 2014 CTRC-American Association for Cancer Research San Antonio Breast Cancer Symposium 12/12/2014 8:12:35 AM
Puma Biotechnology (PBYI) Updates Timeline For Filing New Drug Application 12/3/2014 8:57:53 AM
Puma Biotechnology (PBYI) Sinks On Breast Cancer Drug NDA Delay 12/3/2014 6:48:31 AM
Puma Biotechnology (PBYI) Announces Positive Top Line Results From PB272 Phase 2 Trial In HER2 Positive Metastatic Breast Cancer (Nefertt Trial) 11/14/2014 6:27:16 AM
Puma Biotechnology (PBYI)'s Cancer Drug Neratinib Fails Mid-Stage Study 11/14/2014 6:26:27 AM
Puma Biotechnology (PBYI) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:30:28 AM
Puma Biotechnology (PBYI) Reports Third Quarter 2014 Financial Results 11/11/2014 9:14:27 AM